Medicalgorithmics Gross Profit
The Gross Profit of Medicalgorithmics (MDG.WA) as of Jul 15, 2026 is 20.37 M PLN. In the previous year, Gross Profit was 35.87 M PLN — a change of -43.22% (lower).
Get this data via API
Financial Data API
Gross Profit
20.37 MPLN
YoY
-43.22%
Last updated:
Gross Profit of Medicalgorithmics is 2026 20.37 M PLN. Gross Profit of Medicalgorithmics was 2025 35.87 M PLN. It decreases by -43.22% lower compared to the previous year.
The Medicalgorithmics Gross Profit history
3 Years
10 Years
25 Years
Max
GROSS MARGIN (%)
Date
GROSS MARGIN (%)
Jan 1, 2021
79.49 base
Jan 1, 2022
80.30 base
Jan 1, 2023
83.22 base
Jan 1, 2024
84.86 base
Jan 1, 2025 (e)
65.99 base
Jan 1, 2026 (e)
35.33 base
Jan 1, 2027 (e)
26.50 base
Jan 1, 2028 (e)
20.84 base
| YEAR | GROSS MARGIN (%) |
|---|---|
| 2028 est | 20.84 |
| 2027 est | 26.50 |
| 2026 est | 35.33 |
| 2025 est | 65.99 |
| 2024 | 84.86 |
| 2023 | 83.22 |
| 2022 | 80.30 |
| 2021 | 79.49 |
| 2020 | -30.18 |
| 2019 | 1.20 |
| 2018 | 16.80 |
| 2017 | 22.96 |
| 2016 | 17.57 |
| 2015 | 42.34 |
| 2014 | 46.33 |
| 2013 | 63.06 |
| 2012 | 63.64 |
| 2011 | 51.72 |
Access this data via the Eulerpool API
Medicalgorithmics Revenue
Medicalgorithmics Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
48.35 M PLN
12.13 M PLN
-180.64 M PLN
Jan 1, 2022
62.72 M PLN
16.02 M PLN
-11.86 M PLN
Jan 1, 2023
43.10 M PLN
552,000.00 PLN
-578,000.00 PLN
Jan 1, 2024
24.00 M PLN
-13.86 M PLN
-16.08 M PLN
Jan 1, 2025 (e)
30.87 M PLN
-10.22 M PLN
-10.90 M PLN
Jan 1, 2026 (e)
57.66 M PLN
4.99 M PLN
1.36 M PLN
Jan 1, 2027 (e)
76.87 M PLN
9.73 M PLN
5.43 M PLN
Jan 1, 2028 (e)
97.73 M PLN
16.50 M PLN
11.44 M PLN
Medicalgorithmics Margins
Medicalgorithmics stock margins
The Medicalgorithmics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medicalgorithmics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medicalgorithmics.
3 Years
5 Years
10 Years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
79.49 %
25.09 %
-373.61 %
Jan 1, 2022
80.30 %
25.55 %
-18.91 %
Jan 1, 2023
83.22 %
1.28 %
-1.34 %
Jan 1, 2024
84.86 %
-57.76 %
-67.00 %
Jan 1, 2025 (e)
84.86 %
-33.10 %
-35.33 %
Jan 1, 2026 (e)
84.86 %
8.66 %
2.35 %
Jan 1, 2027 (e)
84.86 %
12.65 %
7.06 %
Jan 1, 2028 (e)
84.86 %
16.89 %
11.71 %
Medicalgorithmics Stock analysis
What does Medicalgorithmics do? Medicalgorithmics is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Medicalgorithmics stock
Gross Profit of Medicalgorithmics is 20.37 M PLN in 2026.
Access this data via the Eulerpool API
Income Statement — Medicalgorithmics
All Key Metrics — Medicalgorithmics
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth